![Regeneron Partners with Mammoth for CRISPR Gene Editing Pursuits](/content/images/size/w600/2024/04/1f1aa719-e914-4aa9-a677-e33c975b10c4.png)
Science
Regeneron Partners with Mammoth for CRISPR Gene Editing Pursuits
Regeneron Pharmaceuticals and Mammoth Biosciences have entered into a strategic collaboration to advance gene editing therapies using CRISPR technology. This partnership combines Mammoth's CRISPR-based gene editing platform with Regeneron's proprietary delivery technologies, aiming to develop treatments for a variety of diseases with a focus on reaching